Skip to main content
Erschienen in: Indian Journal of Pediatrics 2/2019

12.09.2018 | Scientific Letter

Levetiracetam Induced Neuropsychiatric Manifestation in a 5-year-old Boy

verfasst von: Kathiravan M., Sumeet R. Dhawan, Bhanudeep Singanamala, Lokesh Saini, Jitendra Kumar Sahu

Erschienen in: Indian Journal of Pediatrics | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Excerpt

To the Editor: A five-year-old developmentally normal boy presented with six episodes of seizures (Generalized tonic-clonic) for last 6 mo. He was initially started on phenytoin but later switched over to levetiracetam (30 mg/kg) because of poor seizure control. Two weeks after starting of levetiracetam, the child had a change in behavior like poor attention, poor concentration span and decreased interaction with others. Three weeks later, he had intermittent episodes of crying and shouting and hitting other family members without any reason. He also had suicidal tendencies in the form of attempts to cut his wrist with a knife and self-strangulation with a belt. Evaluation for vasculitis (complete blood counts and anti-nuclear antibody), autoimmune encephalitis, worsening epilepsy and other structural etiologies were unremarkable (normal awake and sleep electroencephalography and MRI brain with MR-angiography). Clinical diagnosis of genetic generalised epilepsy was considered. A possibility of levetiracetam induced neuropsychiatric side-effects was considered and levetiracetam was switched over to topiramate. Within few days, he had improvement in interaction with parents, sleep, and behavior. Improvement in symptoms following the withdrawal of levetiracetam suggested a probable causality. He was discharged after 1 wk, and he remained symptom-free over the next 3 mo. …
Literatur
1.
Zurück zum Zitat Lin JJ, Mula M, Hermann BP. Uncovering the neurobehavioural comorbidities of epilepsy over the lifespan. Lancet. 2012;380:1180–92.CrossRefPubMed Lin JJ, Mula M, Hermann BP. Uncovering the neurobehavioural comorbidities of epilepsy over the lifespan. Lancet. 2012;380:1180–92.CrossRefPubMed
2.
Zurück zum Zitat Eddy CM, Rickards HE, Cavanna AE. Behavioral adverse effects of antiepileptic drugs in epilepsy. J Clin Psychopharmacol. 2012;32:362–75.CrossRefPubMed Eddy CM, Rickards HE, Cavanna AE. Behavioral adverse effects of antiepileptic drugs in epilepsy. J Clin Psychopharmacol. 2012;32:362–75.CrossRefPubMed
3.
Zurück zum Zitat Somerville ER, McLaughlin DB, Robinson MK, Berkovic SF. Adjunctive therapy of uncontrolled partial seizures with levetiracetam in Australian patients. Epilepsy Behav. 2007;11:338–42.CrossRefPubMed Somerville ER, McLaughlin DB, Robinson MK, Berkovic SF. Adjunctive therapy of uncontrolled partial seizures with levetiracetam in Australian patients. Epilepsy Behav. 2007;11:338–42.CrossRefPubMed
4.
Zurück zum Zitat Dannaram S, Borra D, Pulluri M, Jindal P, Sharma A. Levetiracetam-induced acute psychotic episode. Innov Clin Neurosci. 2012;9:10–2.PubMedPubMedCentral Dannaram S, Borra D, Pulluri M, Jindal P, Sharma A. Levetiracetam-induced acute psychotic episode. Innov Clin Neurosci. 2012;9:10–2.PubMedPubMedCentral
5.
Zurück zum Zitat Molokwu OA, Ezeala-Adikaibe BA, Onwuekwe IO. Levetiracetam-induced rage and suicidality: two case reports and review of literature. Epilepsy Behav Case Rep. 2015;4:79–81.CrossRefPubMedPubMedCentral Molokwu OA, Ezeala-Adikaibe BA, Onwuekwe IO. Levetiracetam-induced rage and suicidality: two case reports and review of literature. Epilepsy Behav Case Rep. 2015;4:79–81.CrossRefPubMedPubMedCentral
Metadaten
Titel
Levetiracetam Induced Neuropsychiatric Manifestation in a 5-year-old Boy
verfasst von
Kathiravan M.
Sumeet R. Dhawan
Bhanudeep Singanamala
Lokesh Saini
Jitendra Kumar Sahu
Publikationsdatum
12.09.2018
Verlag
Springer India
Erschienen in
Indian Journal of Pediatrics / Ausgabe 2/2019
Print ISSN: 0019-5456
Elektronische ISSN: 0973-7693
DOI
https://doi.org/10.1007/s12098-018-2788-8

Weitere Artikel der Ausgabe 2/2019

Indian Journal of Pediatrics 2/2019 Zur Ausgabe

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.